CD8A and colorectal carcinoma: The Immunoscore scores pathological specimens according to the amount of infiltrating CD8+ and CD3+ lymphocytes in the invasive front and central tumor2, and has been extensively validated as a prognostic marker of CRC beyond the MSI phenotype11.